Podcasts about immunization practices

The FDA issues alert regarding a compounded topical finasteride; plant-based alkaloid shows improvement for smoking cessations; potential new treatment option for GERD; and the CDC's Advisory Committee on Immunization Practices make new recommendations.

James Lyons-Weiler, PhD, explains the bombshell recommendations by a subcommittee of ACIP (Advisory Committee on Immunization Practices), during the first 15 minutes of the show.Then, Rachel Rodriguez and Mimi Miller of the Vires Law Group discuss their formal requests of the Arizona and Pennsylvania Attorney Generals to open criminal investigations of Dr. Anthony Fauci and other officials for alleged crimes committed against their citizens during the COVID-19 pandemic.If you would like to donate towards this effort, you may make a tax-deductible gift at https://formerfedsgroup.org/donate/ and designate it for "AG Action".Reference Linkshttps://informedchoicewa.substack.com/https://vireslaw.group/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

James Lyons-Weiler, PhD, explains the bombshell recommendations by a subcommittee of ACIP (Advisory Committee on Immunization Practices), during the first 15 minutes of the show. Then, Rachel Rodriguez and Mimi Miller of the Vires Law Group discuss their formal requests of the Arizona and Pennsylvania Attorney Generals to open criminal investigations of Dr. Anthony Fauci and other officials for alleged crimes committed against their citizens during the COVID-19 pandemic. If you would like to donate towards this effort, you may make a tax-deductible gift at https://formerfedsgroup.org/donate/ and designate it for "AG Action". Reference Links https://informedchoicewa.substack.com/ https://vireslaw.group/

Disclaimer:   The views and opinions expressed during this podcast are those of the individuals participating and do not necessarily represent the official position or opinion of the SOGC.  Summary:  In this episode, Dr. Jocelynn Cook, Chief Scientific Officer at the SOGC, is joined by experts Dr. Chelsea Elwood and Dr. Steve Schofield to discuss the emerging Oropouche virus and the potential risks it poses for pregnant individuals. Tune in for an informative episode that explores symptoms, prevention methods and the latest public health guidelines for patients.About Dr. CookDr. Jocelynn Cook is the Chief Scientific Officer for the SOGC. She has a PhD in Reproductive Physiology from the Medical University of South Carolina. She oversees all work related to Continuing Medical Education, Clinical Practice Guidelines, Research, Accreditation, Global Health and Indigenous Health. Her professional career has focused on issues related to maternal-fetal medicine including substance abuse during pregnancy, preterm birth and maternal mortality.About Dr. SchofieldDr. Steve Schofield has worked with the Canadian military for more than 20 years. His focus is communicable disease control and prevention. In this role, he advises on how to protect deploying troops including through use of vaccines and countermeasures to prevent insect bites. Steve has been allowed to play with people way smarter than him, including for some 20 years with the Canadian Committee to Advise in Tropical Medicine and Travel (CATMAT), and has spent shorter stints on working groups for the Canadian National Advisory Committee on Immunization and the Unites States Advisory Committee on Immunization Practices. In a past life, he obtained a PhD from Imperial College which involved chasing things like tsetse flies in Zimbabwean national parks. He still sometimes chases insects and their ilk, including on his rural property, where he practices what he preaches to avoid being bitten by the Borrelia-infected ticks that have moved in over the last few years.About Dr. ElwoodDr. Chelsea Elwood completed her B.M.Sc. and M.Sc. in Microbiology and Immunology at the University of Western Ontario completed her medical training at the University of British Columbia including a fellowship in Reproductive Infectious Disease. She has a varied clinical practice including being the Medical Director of the Oak Tree clinic and the antimicrobial stewardship program at BCWH which focus on infections as they related to women's health and reproduction.  She has authored numerous guidelines and lead provincial and national responses in those areas.

Send us a textIn this conversation, Dr. Paul Offit and pediatrician Jessica Hochman discuss the importance of vaccinations, the challenges of vaccine hesitancy among parents, and the need for nuanced conversations in public health. They explore the impact of the COVID-19 pandemic on public trust, and the science behind vaccination schedules. The discussion emphasizes the importance of understanding parental concerns while advocating for the safety and efficacy of vaccines. About Paul A. Offit, MD!Paul A. Offit, MD, is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, and a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines.He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, a Research Career Development Award from the National Institutes of Health, and the Sabin Vaccine Institute Gold Medal.Dr. Offit has published more than 160 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC. For this achievement, Dr. Offit received the Luigi Mastroianni and William Osler Awards from the University of Pennsylvania School of Medicine, the Charles Mérieux Award from the National Foundation for Infectious Diseases, and he was honored by Bill and Melinda Gates during the launch of their Foundation's Living Proof Project for global health.In 2009, Dr. Offit received the President's Certificate for Outstanding Service from the American Academy of Pediatrics. In 2011, he received the Humanitarian of the Year Award from the BiologicDr Jessica Hochman is a board certified pediatrician, mom to three children, and she is very passionate about the health and well being of children. Most of her educational videos are targeted towards general pediatric topics and presented in an easy to understand manner. For more content from Dr Jessica Hochman:Instagram: @AskDrJessicaYouTube channel: Ask Dr JessicaWebsite: www.askdrjessicamd.com-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA Do you have a future topic you'd like Dr Jessica Hochman to discuss? Email Dr Jessica Hochman askdrjessicamd@gmail.com.The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditions or formulate treatment plans for specific individuals. If you have a concern about your child's health, be sure to call your child's health care provider.

It's Wednesday, February 5th, A.D. 2025. This is The Worldview in 5 Minutes heard on 125 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark and Adam McManus Pakistani Christian brothers released from prison Praise God! Two Christian brothers are now free from prison in Pakistan. A court acquitted the twin brothers last month. Eighteen-year-olds Sahil and Raheel Shahid were facing false Islamic blasphemy accusations. The brothers' attorney told Morning Star News, “We believe that this case was a conspiracy against the Christian residents so that vested interests could grab their land and properties.” False blasphemy accusations are an increasing problem in Pakistan, a 97%-Muslim nation, The country is ranked 8th on the Open Doors' World Watch List of the most difficult places to be a Christian.  Countries in which religious nationalism predominates Pew Research released a global report on religious nationalism. The report identified religious nationalists as people who believe in the historically predominant religion of their country and believe that their religion should influence their laws and leaders. Religious nationalism was most common in Kenya for countries with Christian roots. For Buddhists, the country with the most religious nationalism was Thailand. For Hindus, it was India. For Jews, it was Israel. And for Muslims, it was Indonesia and Bangladesh.  Religious nationalism for Christians was most common in Africa and South America while being the least common in Europe. The United States was somewhere in-between with just 6% of adults identifying as religious nationalists. Psalm 33:12 says, “Blessed is the nation whose God is the LORD, the people He has chosen as His own inheritance.” Senator Cassidy explained his conditional support of RFK, Jr. In the United States, Senator Bill Cassidy of Louisiana, a moderate Republican who voted to convict President Donald Trump in February 2021 of “incitement of insurrection”, was a key vote as member of the Senate Finance Committee which considered Robert F. Kennedy, Jr. to be the next Secretary of Health and Human Services. As a physician, Senator Cassidy was especially concerned with Kennedy's questions about a possible link between childhood vaccines and autism.  Before the committee vote, Cassidy made this statement from the Senate floor. CASSIDY: “Now, Mr. Kennedy and the administration reached out seeking to reassure me regarding their commitment to protecting the public health benefit of vaccination. To this end, Mr. Kennedy and the administration committed that he and I would have an unprecedentedly close, collaborative working relationship if he is confirmed. “We will meet or speak multiple times a month. If confirmed, he will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommendations without changes. CDC will not remove statements on their website, pointing out that vaccines do not cause autism. “He committed that they help committee chair, whether it's me or someone else, may choose a representative on any board or commission formed to review vaccine safety. These commitments, and my expectation that we can have a great working relationship to make America healthy again, is the basis of my support. “If Mr. Kennedy is confirmed, I will use my authority as chairman of the Senate committee, with oversight of HHS, to rebuff any attempt to remove the public's access to life-saving vaccines without iron-clad, causational, scientific evidence that can be accepted and defended before the mainstream scientific community and before Congress.” RFK, Jr. voted out of Senate Committee On Tuesday, the U.S. Senate Finance Committee voted to advance President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.  The committee voted 14-13 along party lines. Committee Chair Mike Crapo of Idaho oversaw the committee vote. CRAPO: “We now have not only a quorum, but all members of the committee are present. I move that the committee favorably report the nomination of the Honorable Robert F. Kennedy, Jr of California to be Secretary of Health and Human Services. Is there a second?” COMMITTEE MEMBER: “Second.” CLERK: “Mr. Chairman, the final tally was 14 ayes, 13 nays. CRAPO: “The vote was 14-13. The nomination is reported favorably.” Kennedy's nomination now goes before the full U.S. Senate where he needs a simple majority or a minimum of 51 votes to be confirmed. Trump: Military will no longer pay for abortion travel Last Tuesday, the Trump administration announced the military will no longer cover travel expenses for services members to get abortions. U.S. Republican Senator Tommy Tuberville of Alabama notably stood against the Defense Department's funding for abortion under Biden's leadership. He said, “For the past two years, I have been sounding the alarm about the Pentagon's illegal and immoral practice of using taxpayer dollars to fund abortions. I took a lot of heat when I stood alone for nearly a year in holding senior Pentagon promotions over this—but as of today, it was all worth it.” Galatians 6:9 says, “And let us not grow weary while doing good, for in due season we shall reap if we do not lose heart.” Department of Education getting phased down The Trump administration is beginning to scale back the Department of Education.  Already, the administration has placed dozens of employees on paid administrative leave. This is part of a broader effort to remove hires based on diversity, equity, and inclusion initiatives.  The administration is also working on an executive order that would begin the process of eliminating the Education Department entirely. GDP slowed In economic news, the U.S. Gross Domestic Product slowed down during the last three months of 2024. The economy grew by 2.3% during the fourth quarter of last year, down from 3.1% during the third quarter. Economists had expected 2.5% growth for the fourth quarter.  Also, the Federal Reserve held its key interest rate at 4.25%-4.5%, saying inflation remains somewhat elevated. The Fed cut interest rates three times since September 2024 and President Trump is calling for more cuts.  Virginia voted down anti-homeschooling bill Virginia lawmakers voted down a bill that would have eliminated the religious exemption from the state's public education requirements.  The bill would have added many regulations for parents who educate their children at home for religious reasons. Republican Governor Glenn Youngkin wrote on X, “I stand with parents across Virginia in opposition to Senate Bill 1031. We cannot allow this attack on homeschooling to become law.” Court: San Francisco must rehire employees who refused COVID shot And finally, a federal appeals court ruled in favor of Christian employees who were fired for not getting a COVID-19 shot in California. The city of San Francisco must now rehire workers who were terminated for refusing the shot. The ruling stated, “Appellants' coerced decision between their faith and their livelihood imposed emotional damage which cannot now be fully undone.  … [San Francisco's] finding that Appellants' religious beliefs were insufficient to warrant any accommodations can only be described as a ‘dignitary affront.' ... The circumstances surrounding Appellants' termination constitute irreparable harm.” Close And that's The Worldview on this Wednesday, February 5th, in the year of our Lord 2025. Subscribe by Amazon Music or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. Or get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

If the Senate confirms Robert F. Kennedy Jr. — a vaccine skeptic — to lead the Department of Health and Human Services, he would control a powerful group of federal vaccine advisors.Guests:Ron Balajadia, Hawaii Department of Health immunization branch chiefDorit Reiss, University of California, San Francisco, professor of public health law Dr. Sarah Long, former member of the Advisory Committee on Immunization Practices and Drexel University, professor of pediatric infectious diseaseDr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia.Richard Hughes IV, attorney with Epstein Becker Green Per Fischer, CEO, MinervaXLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Joining us for this episode of Managed Care Cast is Robert H. Hopkins, Jr, MD, mnedical director at the National Foundation for Infectious Diseases and NFID liaison to the Advisory Committee on Immunization Practices, who will help separate fact from fiction about avian influenza and discuss what needs to be done to prevent a future escalation.

Our guest today is Dr. Sandra Adamson Fryhofer, Member of the American Medical Association's Board of Trustees. Dr. Fryhofer, a board-certified physician of internal medicine, was elected as a trustee in June 2018 and served as chair of the board in 2022–23. A graduate of Emory University School of Medicine, Dr. Fryhofer also maintains a full-time general internal medicine private practice in Atlanta. Among her numerous positions, she has served as AMA's liaison to the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

Three years on, COVID is clearly here to stay. So what do we do now? Drawing on his expertise as one of the world's top virologists, Dr. Paul Offit helps weary readers address that crucial question in this brief, definitive guide. As a member of the FDA Vaccine Advisory Committee and a former member of the Advisory Committee for Immunization Practices to the CDC, Offit has been in the room for the creation of policies that have affected hundreds of millions of people.In these pages, he marshals the power of hindsight to offer a fascinating frontline look at where we were, where we are, and where we're heading in the now-permanent fight against the disease. Accompanied by a companion website populated with breaking news and relevant commentary, this book contains everything you need to know to navigate COVID going forward. Offit addresses fundamental issues like boosters, immunity induced by natural infection, and what it means to be fully vaccinated. He explores the dueling origin stories of the disease, tracing today's strident anti-vax rhetoric to twelve online sources and tracking the fallout. He breaks down long COVID—what it is, and what the known treatments are. And he looks to the future, revealing whether we can make a better vaccine, whether it should be mandated, and providing a crucial list of fourteen takeaways to eradicate further spread. Filled with pragmatic analysis and sensible advice, TELL ME WHEN IT'S OVER is for anyone interested in finding new solutions to the new normal.

Thank you for joining us for another episode of OccPod. In this episode, Erin and Dr. Nabeel are joined by Dr. Amy Behrman for a conversation about COVID-19 and outbreaks of Measles, and how workers can protect themselves. Dr. Behrman is the Medical Director of Occupational Medicine Services and Professor of Emergency Medicine at the Hospital of the University of Pennsylvania. Dr. Behrman serves on the National Adult and Influenza Immunization Summit which is dedicated to improving vaccine use as recommended by the CDC Advisory Committee on Immunization Practices.

Dr. Paul Offit returns to the program to discuss his latest book, Tell Me When It's Over: An Insider's Guide to Deciphering Covid Myths and Navigating Our Post-Pandemic World. Dr. Offit is the Director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is also an internationally recognized expert in the fields of virology and immunology and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention.  Tell Me When It's Over is a definitive guide that helps readers find new solutions to navigating the “new normal”. Brimming with pragmatic analysis and sensible advice, this book provides fact-based information in a world where science is highly politicized – and polarizing… In this episode, we cover: What inspired Dr. Offit's latest book. How to spot helpful versus misleading information surrounding the global pandemic.  Whether or not the early clinical trials of the COVID-19 vaccines were misleading.  The four groups of individuals who are at high risk of contracting serious illnesses. To learn more about Dr. Offit and his work, click here now! Take advantage of a 5% discount on Ekster accessories by using the code FINDINGGENIUS. Enhance your style and functionality with premium accessories. Visit bit.ly/3uiVX9R to explore latest collection. Episode also available on Apple Podcasts: http://apple.co/30PvU9

As a member of the FDA Vaccine Advisory Committee and a former member of the Advisory Committee for Immunization Practices to the CDC, Dr. Paul Offit has been in the room for the creation of policies that have affected hundreds of millions of people. Four years after the outbreak of COVID-19, he reflects on our response to the pandemic: what went well and what didn't. Shermer and Offit discuss: mRNA vaccines • loss of trust in medical and scientific institutions • overall assessment of what went right and wrong • mandates vs. recommendations • economic costs • lab leak hypothesis vs. zoonomic hypothesis • debating anti-vaxxers • treatments • high risk vs. low risk groups Paul Offit is the Director of the Vaccine Education Center at the Children's Hospital of Philadelphia and Professor of Vaccinology and Professor of Pediatrics at the University of Pennsylvania. Offit has published more than 170 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC and WHO.

Guess what? The CDC's Advisory Committee on Immunization Practices had a unanimous vote in favor of a preferential recommendation of vaccines for the cool adults who are 65 and older—one of these options is adjuvanted influenza vaccines.1 Talk about a milestone in the world of public health! Now the burning question is why on earth did they decide on adjuvant vaccines? Let's unravel this immunization mystery together, shall we? Reference: Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 influenza season. MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1 USA-CRP-23-0037 12/23

Guess what? The CDC's Advisory Committee on Immunization Practices had a unanimous vote in favor of a preferential recommendation of vaccines for the cool adults who are 65 and older—one of these options is adjuvanted influenza vaccines.1 Talk about a milestone in the world of public health! Now the burning question is why on earth did they decide on adjuvant vaccines? Let's unravel this immunization mystery together, shall we? Reference: Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 influenza season. MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1 USA-CRP-23-0037 12/23

Guess what? The CDC's Advisory Committee on Immunization Practices had a unanimous vote in favor of a preferential recommendation of vaccines for the cool adults who are 65 and older—one of these options is adjuvanted influenza vaccines.1 Talk about a milestone in the world of public health! Now the burning question is why on earth did they decide on adjuvant vaccines? Let's unravel this immunization mystery together, shall we? Reference: Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 influenza season. MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1 USA-CRP-23-0037 12/23

Drs Nicholas Silvestri and Michael Hehir discuss best practices for primary care physicians who see patients with myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990463). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources New and Emerging Treatments for Myasthenia Gravis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407383/ Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/ Myasthenia Gravis With Elderly Onset at Advanced Age https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991148/ Myasthenia Gravis, Respiratory Function, and Respiratory Tract Disease https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132430/ Myasthenic Crisis https://pubmed.ncbi.nlm.nih.gov/37114503/ Telemedicine Visits in Myasthenia Gravis: Expert Guidance and the Myasthenia Gravis Core Exam (MG-CE) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057373/ MGFA Partners in MG Care Program https://myasthenia.org/Professionals/MGFA-Partners-in-MG-Care MGFA List of Cautionary Drugs https://myasthenia.org/Portals/0/Cautionary%20Drugs.pdf

Hear from physician experts on strategies to address vaccine hesitancy with patients and updates on current COVID variants, flu, and RSV vaccines. This episode was created in collaboration with the PermanenteDocs Chat podcast, and is hosted by family physician Alex McDonald, MD, featuring guest Sandra Fryhofer, MD, AMA liaison to the CDC's Advisory Committee on Immunization Practices and Immediate Past Chair of the AMA Board of Trustees.

In this episode, hosts Marla Dalton, PE, CAE, and William Schaffner, MD, talk with Carol J. Baker, MD, a leader in group B Streptococcus prevention and a passionate advocate for maternal immunization to help protect mothers and infants. She shares her perspectives on the most significant changes throughout her career, including the development of vaccines and antivirals as well as the inclusion of pregnant women in clinical trials for vaccines and drugs. As a former competitive swimmer and now a daily walker, she has brought her energy and drive to national leadership positions, including as past president of NFID, as well as former chair of the Advisory Committee on Immunization Practices. NFID presented her with the John P. Utz Leadership Award in 2009 in recognition of her leadership and service to NFID and the field of infectious diseases. She was elected to the National Academy of Medicine in 2019.  

Everyone six months and older needs to get the updated COVID vaccine (2023-2024 Covid vaccine). Joining to discuss why and when people should get it, as well as how much it'll cost, is Sandra Fryhofer, MD, the AMA's immediate past board chair and liaison to ACIP, the CDC's Advisory Committee on Immunization Practices. American Medical Association CXO Todd Unger hosts.

In this episode, Angela Branche, MD, discusses the Advisory Committee on Immunization Practices recommendations for RSV vaccines in older adults, including: Use of shared clinical decision-making How to approach the conversation about the RSV vaccine with patientsKey populations who may benefit the most, such as those at risk for severe RSV disease (eg, increasing age and persons who are frail or have cardiopulmonary comorbidities)Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkLink to full program: https://bit.ly/3nb25xeLink to downloadable slides: https://bit.ly/3nb25xe

In his weekly clinical update, Dr. Griffin discusses modeling poliovirus transmission and responses in New York State, FDA approves first vaccine for pregnant individuals to prevent RSV in infants, prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, Nirmatrelvir resistance – de novo E166V/L50V mutations in an immunocompromised patient treated with prolonged nirmatrelvir/ritonavir monotherapy leading to clinical and virological treatment failure, incidence of new-onset hypertension post–COVID-19: comparison with influenza, and post-acute sequelae of COVID-19 at 2 years. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Modeling poliovirus transmission and responses in New York State (JID) FDA approves first vaccine for pregnant individuals to prevent RSV in infants (FDA) Prevention and control of seasonal influenza with vaccines (CDC) De novo E166V/L50V mutations in an immunocompromised patient treated with nirmatrelvir/ritonavir (CID) Incidence of new-onset hypertension post–COVID-19 (Hypertension) Postacute sequelae of COVID-19 at 2 years (Nature Medicine) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1038 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

RSV vaccination recommendation for adults from the CDC's Advisory Committee on Immunization Practices and CDC health advisories on measles and malaria for summer travelers. AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also discusses trending studies on e-cigarette sales and maternal mortality, and the USPSTF recommendation to screen adults for anxiety. American Medical Association CXO Todd Unger hosts. Become an AMA member today to support more programming like this: https://bit.ly/AMAJoinRenew

Paul A. Offit, MD, is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, and a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines. He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, a Research Career Development Award from the National Institutes of Health, and the Sabin Vaccine Institute Gold Medal. Dr. Offit has published more than 150 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq®, recommended for universal use in infants by the CDC. For this achievement, Dr. Offit received the Luigi Mastroianni and William Osler Awards from the University of Pennsylvania School of Medicine, the Charles Mérieux Award from the National Foundation for Infectious Diseases, and was honored by Bill and Melinda Gates during the launch of their Foundation's Living Proof Project for global health. Read Dr. Offit's complete bio here: https://www.chop.edu/doctors/offit-paul-a _______________________________________________________ JOWMA Podcast | Ep. 1 How to Fool Yourself Less Often: Medical Decision Making for Regular People https://anchor.fm/jowma/episodes/Ep--1-How-to-Fool-Yourself-Less-Often-Medical-Decision-Making-for-Regular-People-eav2pu _______________________________________________________ Become a JOWMA Member! www.jowma.org  Follow us on Instagram! www.instagram.com/JOWMA_org  Follow us on Twitter! www.twitter.com/JOWMA_med  Follow us on Facebook! https://www.facebook.com/JOWMAorg/ Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

Dr. Litjen (L.J) Tan's full bio: Prior to joining the Immunization Action Coalition (IAC), Dr. Tan was the director of medicine and public health at the American Medical Association (AMA) a position he held since 2008. From 1997 to 2008, he was the AMA's director of infectious disease, immunology, and molecular medicine.Dr. Tan was a voting member of the Department of Health and Human Services' National Vaccine Advisory Committee from 2009 to 2013, where he served on the adult immunization, vaccine safety, and healthcare worker immunization working groups, and chaired the immunization infrastructure working group. He also served for more than ten years as the AMA's liaison to the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, where he served on the influenza, pneumococcal, zoster, and adult immunization working groups.He co-founded and currently co-chairs the National Adult and Influenza Immunization Summit. He continues to advise the ESWI Flu Summit and the APACI Flu Summit. He serves or has served on the steering committees/advisory boards of the 317 Coalition, the Adult Vaccine Access Coalition (AVAC), the Unity (United for Adolescent Vaccination) Consortium, the National Network for Immunization Information, and the National Viral Hepatitis Roundtable. Dr. Tan also serves, or has served on the National Quality Forum's Adult Immunizations Expert Committee, the Pharmacy Quality Alliance's Adult Immunization Working Group, and numerous national and international expert and technical advisory committees, including panels for the Centers for Medicare and Medicaid Services, The Joint Commission, and the Centers for Disease Control and Prevention, on issues ranging from vaccine hesitancy, to immunization quality measurement development, to adult immunizations, to immunization access and delivery. In 2007, he founded the National Immunization Congress and organized its 2007 and 2010 meetings.Dr. Tan is an editor for Vaccine, BMC Infectious Diseases, Medscape Infectious Diseases, and a member of the ESCMID Vaccine Study Group and has published more than 50 peer-reviewed articles. Resources: www.immunize.orgwww.cdc.orgwww.ama-assn.orgwww.izsummitpartners.orgwww.vaccinateyourfamily.orgwww.goodhealthwins.org

In this podcast, William Schaffner, MD, discusses recent updates to the Advisory Committee on Immunization Practices' (ACIP) immunization recommendations in adults aged 65 or older, including pneumococcal, zoster, Hepatitis B, COVID-19, influenza, and tetanus, diphtheria, and pertussis vaccines.

Routine pediatric vaccines are declining and 97% of pediatric influenza deaths are in unvaccinated children. Join host Geoff Wall, with guest Jake Galdo, as they discuss what the heck is happening with pediatric vaccines and how the healthcare community can step up.The GameChangerThe Advisory Committee on Immunization Practices provides recommendations for routine vaccines for all persons. Pharmacists are an integral part of ensuring adherence to vaccine schedules. Differences in state scope of practice may influence what vaccines may be administered, but not what vaccines can be recommended.Show Segments00:00 - Introductions00:53 - Pediatric Vaccine Coverage02:51 - Connecting to Practice: How Pharmacists Can Help14:21 - The GameChanger: Pediatric COVID Vaccines26:22 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpactManaging Network Facilitator, CPESN Health EquityCEO, SeguridadReferences and ResourcesVaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2021-22 School Year. Redeem your CPE hereCPE (Pharmacist)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the current state of pediatric vaccinations in the US2. Describe clinical information to be collected during pediatric vaccinations0.05 CEU/0.5 HrUAN: 0107-0000-23-100-H01-PInitial release date: 02/20/2023Expiration date: 02/20/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagramDownload the CEimpact App for Free Continuing Education + so much more!

Dr. Paul A. Offit is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines. He is a scientist, a skeptic, a thinker and an individual deeply passionate about children's health. This week we sit down again to discuss the latest with Covid, vaccines and children's health as new data has prompted a new discussion. I hope that you enjoy my latest conversation with Dr. Offit,   Dr. M

An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medicine Experience 2022 conference, listen as we discuss when an RSV vaccine may be approved and how to overcome barriers to the implementation of vaccines for older adults in primary care settings.Hear answer to questions such as:When might potential RSV vaccines be available, and when might the Advisory Committee on Immunization Practices make recommendations on their use?How will the vaccine roll out? Who would receive the vaccine first?If approved, what will the RSV vaccination schedule be?How can we overcome vaccine hesitancy?PresentersJohn J. Russell, MD, FAAFPClinical Professor of Family and Community MedicineSidney Kimmel College of MedicineThomas Jefferson UniversityPhiladelphia, PennsylvaniaChair, Department of Family and Community MedicineAbington-Jefferson HealthAbington, PennsylvaniaLaura Hurley, MD, MPHAssociate Professor of MedicineDivision of General Internal MedicineDepartment of MedicineUniversity of Colorado Anschutz Medical CampusAurora, ColoradoPrimary Care PhysicianDivision of General Internal MedicineDepartment of MedicineDenver HealthDenver, ColoradoPamela Rockwell, DO, FAAFPProfessorFamily MedicineUniversity of Michigan Medical SchoolAnn Arbor, MichiganView the full program at:https://bit.ly/3Wt87GI

In this week's podcast, NACCHO Government Affairs team members Adriane Casalotti and Kerry Allen provide an update on the status of federal funding and discuss NACCHO's priorities for a possible Fiscal Year 2023 omnibus appropriations bill. They also review the progress made on legislation to establish a public health loan repayment program, and ongoing NACCHO efforts to get that across the finish line before the 117th Congress ends, including an upcoming opportunity for NACCHO members to engage with their federal lawmakers in support of the program. Adriane describes the implications of and discussion around the recent CDC Advisory Committee on Immunization Practices recommendations on the COVID-19 vaccine. Finally, the team reminds listeners that many public health policy decisions will hinge on the outcome of the upcoming midterm elections and urges everyone to vote. Later in the program, we talk about one of the latest outbreaks – monkeypox (MPX) – with Dr. Philip Huang, Director of the Dallas County Health and Human Services, Andy Meléndez Salgado, MPH, Manager of the Public Health Emergencies and Environmental Health Unit of the New Orleans Health Department, and Dr. Judith Shlay, Associate Director of the Public Health Institute at Denver Health. We discuss how local health departments are working to reach populations at risk for MPX and how lessons learned from COVID-19 response are helping local jurisdictions to address MPX.

Thank you for joining us for another episode of OccPod, the official podcast of the American College of Occupational and Environmental Medicine. This episode serves as a continuation of a special series investigating vaccinations. Funding for this series was made possible (in part) by the Centers for Disease Control and Prevention. In this episode, Erin and Dr. Nabeel are joined by guest Dr. Amy Behrman to discuss updates to COVID-19 vaccinations, including the latest bivalent boosters. Dr. Behrman is the Medical Director of Occupational Medicine Services and Professor of Emergency Medicine at the Hospital of the University of Pennsylvania. She serves on the National Adult and Influenza Immunization Summit which is dedicated to improving vaccine use as recommended by the CDC Advisory Committee on Immunization Practices. As always, thank you for joining us for OccPod. Don't forget to subscribe so you can hear the latest information related to occupational and environmental medicine, vaccinations, and a host of other topics!

In a special episode of the newscast, Dr. Marcus Plescia, ASTHO's Chief Medical Officer, explains the CDC's Advisory Committee on Immunization Practices decision earlier this week. The committee voted Thursday to add pediatric COVID-19 vaccines to the CDC's immunization schedule for children. ASTHO News Release: Statement from ASTHO on COVID-19 Vaccine Recommendations

Full Hour | In today's third hour, Dom welcomes back Megan Brock, a mom from out in Bucks County, who along with other parents continues their crusade to understand what's being done inside schools, particularly centered on Coronavirus lockdowns. Today, Brock presented in Harrisburg to State Senate a new bill for parental rights along with State Senator and Gubernatorial Candidate Doug Mastriano. Brock tells about the new bill presented by the State Senator, stressing the necessity for transparency from both the State government and local school boards when determining decisions on curriculum and lockdowns. Then, Dom welcomes back Dr. Marty Makary, author of The Price We Pay: What Broke American Healthcare…and How To Fix It, to discuss a report that the CDC Advisory Committee on Immunization Practices would be voting on whether to add the COVID-19 to the childhood immunization schedule, with Dr. Makary expressing why he's not there yet to require something like this. Then, Giordano asks Makary about a report out of Boston University about a new strain of COVID developed in a lab that has a 80% kill rate, which kicks off a conversation about gain-of-function research and whether this is at all beneficial to the health of Americans. (Photo by Getty Images)

Dom welcomes back Dr. Marty Makary, author of The Price We Pay: What Broke American Healthcare…and How To Fix It, to discuss a report that the CDC Advisory Committee on Immunization Practices would be voting on whether to add the COVID-19 to the childhood immunization schedule, with Dr. Makary expressing why he's not there yet to require something like this. Then, Giordano asks Makary about a report out of Boston University about a new strain of COVID developed in a lab that has a 80% kill rate, which kicks off a conversation about gain-of-function research and whether this is at all beneficial to the health of Americans. (Photo by Getty Images)

This episode discusses five MMWR reports. The first report provides early evidence of protection from monkeypox after a single dose of the JYNNEOS vaccine. The second report describes the low monkeypox transmission risk among residents of Cook County Jail in Chicago. The third report examines acute respiratory illnesses among children and teens associated with enterovirus D68. The fourth report highlights the Advisory Committee on Immunization Practices' recommendations for the cholera vaccine. And the last report examines the effectiveness of a second COVID-19 booster dose against hospitalization and death among nursing home residents.

GUEST OVERVIEW: Paul Offit is a pediatrician specializing in infectious diseases and an expert on vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine that has been credited with saving hundreds of lives every day. Offit is the Maurice R. Hilleman professor of vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania and director of The Vaccine Education Center at Children's Hospital of Philadelphia (CHOP). Offit is currently a member of National Institutes of Health (NIH) working group on vaccines, a subgroup of the "Accelerating COVID-19 Therapeutic Interventions and Vaccines" (ACTIV) comprised of experts to combat COVID-19. He is also a member of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC). Previously, he was a member of the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices. Offit is a board member of Vaccinate Your Family, The Franklin Institute, and Autism Science Foundation.

Dr. Paul A. Offit is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines. He is a scientist, a skeptic, a thinker and an individual deeply passionate about children's health. This week we sit down to discuss Covid, vaccines and children's health. I hope that you enjoy my conversation with Dr. Offit,   Dr. M

Monkeypox questions on transmission, testing, treatment, prevention, personal protective equipment (PPE) and more answered by Sandra Fryhofer, MD, Chair, American Medical Association Board of Trustees and AMA liaison to the Advisory Committee on Immunization Practices. AMA CXO Todd Unger hosts. Monkeypox resources available here: https://www.ama-assn.org/topics/monkeypox

About our guest today Paul A. Offit, MD, is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.Dr. Offit is an internationally recognized expert in the fields of virology and immunology and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine, and a co-editor of the foremost vaccine text, Vaccines.YOU BET YOUR LIFEPlease subscribe to our podcast on apple or amazon and write us a great review. You can make suggestions for guests and topics on our website below. Thanks for listening. The Pediatric Lounge - A Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into just what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between.The conversations are not intended as medical advice and the opinions expressed are solely those of the host and guest.

Vaccine development is considered one of the greatest achievements of public health and medical science with millions of lives saved worldwide from many once-deadly infectious diseases.  Fortunately, most parents readily accept all vaccines recommended by the American Academy of Pediatrics (AAP).  However, vaccine hesitancy is becoming increasingly prevalent. Pediatric Resident, Dr. Caroline Fu, joins Associate Professor of Pediatrics at MCG, Dr. Donna Moore, to discuss childhood vaccine hesitancy.  After listening to this podcast, learners should be able to: 1. Recognize the public health concerns of childhood vaccination refusal and delays. 2. Understand common objections and concerns about vaccines and know how to dispel misconceptions. 3. Utilize communication strategies for counseling vaccine hesitant parents. 4. Know how to access reputable resources to provide parents who would like additional resources. 5. Explain the few true medical contraindications to vaccines vs. religious or philosophical objections. 6. Review tips on how to approach parents who continue to refuse vaccines despite extensive counseling. FREE CME Credit (requires free sign-up):  https://mcg.cloud-cme.com/course/courseoverview?P=0&EID=11406  References:  Wolfe, RM and Sharp, LK.  Anti-Vaccinationists Past and Present.  BMJ.  2002; 325:430.  AAP COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE, AAP COMMITTEE ON INFECTIOUS DISEASE, AAP COMMITTEE ON STATE GOVERNMENT AFFAIRS, AAP COUNCIL ON SCHOOL HEALTH, AAP SECTION ON ADMINISTRATION AND PRACTICE MANAGEMENT.  Medical versus Nonmedical Immunization Exemptions for Child Care and School Attendance.  2016; 138 (3): e20162145  Edwards KM, Hackell JM, AAP THE COMMITTEE ON INFECTIOUS DISEASES, THE COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE.  Countering Vaccine Hesitancy.  Pediatrics.  2016; 138(3): e20162146  Natbony, J and Genies, M. Vaccine Hesitancy and Refusal in Brief.   Pediatrics in Review.  2016; 40.1(22-3)  Smith, M.  Vaccine Safety: Medical Contraindications, Myths, and Risk Communication.  Pediatrics in Review.  2015; 36:6 (227-236).  Healy, MC and Pickering, LK.  How to Communicate with Vaccine-Hesitant Parents.  2011; 127:S127-S133.  McKee, C and Bohannon, K.  Exploring the Reasons Behind Parental Refusal of Vaccines.  Journal of Pediatric Pharmacology and Therapeutics.  2016; 1:2 (104-9).  Wombwell E, Fangman MT, Yoder AK, and Spero DL.  Religious Barriers to Measles Vaccination.  Journal of Community Health.  2015; 40:597-604.  Singh, K and Mehta, S.  The clinical development process for a novel preventative vaccine: An overview.  Journal of Postgraduate Medicine. 2016; 62(1): 4-11.    Girotto, J.  What does full FDA Approval Mean for a Vaccine already authorized for emergency use?  UConn Today.  August 19, 2021. https://today.uconn.edu/2021/08/what-does-full-fda-approval-mean-for-a-vaccine-already-authorized-for-emergency-use/  Quinn SC, Jamison AM, Freimuth V.  Communicating effectively about emergency use authorization and vaccines in the COVID-19 pandemic.  Am J Public Health.  2021; 111(3):355-358.  JD Grabstein. What the World Teaches, Applied to Vaccines and Immunoglobulins. Vaccine.  2013 April 12;31(16):2011-23.doi: 10.1016/j.vaccine.2013.02.026. Epub 2013 Feb 26.  World Health Organization. Ten health issues who will tackle this year. 2019.  https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 Resources for parents and providers  CDC provider resources for conversation with vaccine hesitant parents: https://www.cdc.gov/vaccines/hcp/conversations/index.html https://www.cdc.gov/vaccines/parents/index.html (CDC vaccines for parents resource)  https://www.cdc.gov/vaccines/pubs/pinkbook/index.html (PinkBook CDC)  https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/hepb.html (Advisory Committee on Immunization Practices; contraindications and precautions for vaccines)  https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/thimerosal-and-vaccines#cstat https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-ingredients CHOP vaccine ingredients   https://www.chop.edu/centers-programs/vaccine-education-center/resources/vaccine-and-vaccine-safety-related-qa-sheets CHOP Vaccine safety q and a  https://www.vaccinesafety.edu/Religion.htm https://downloads.aap.org/DOPCSP/SOID_RTV_form_01-2019_English.pdf AAP Refusal to Vaccinate Form - English  https://downloads.aap.org/DOPCSP/SOID_RTV_form_01-2019_Spanish.pdf AAP Refusal to Vaccinate Form - Spanish  https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html COVID vaccine tracker (details the vaccine trials and approval process).   

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277 Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We'll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won't want to miss this episode.  Episode resource links: Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine.   https://www.medscape.com/viewarticle/967675#vp_1   Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press.   Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277 Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We'll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won't want to miss this episode.  Episode resource links: Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine.   https://www.medscape.com/viewarticle/967675#vp_1   Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press.   Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Richard Onorato

EpidemiologyCaused by double stranded DNA virus, genus orthopoxvirus, closely related to smallpox and cowpox.Discovered in 1958 in monkeys with first human case recorded in 1970 in the Democratic Republic of Congo. (CDC) It is a zoonotic disease , meaning it is transmitted from animal to humans, with primary reservoir in squirrels, Gambian poached rats, dormice, different species of monkeys and others. First reported in the U.S. in 2003. Cases were related to pet prairie dogs that had been housed with monkeypox virus infected African rodents, imported from Ghana (WHO)There are 2 clades (having evolved from same ancestral line) of the disease. The current outbreak is from the West African lineage. (WHO)West African – milder disease, 1-3% fatalityCongo Basin – severe disease, 10% fatality Due to the similarity in the viruses, immunization against smallpox has been found to prevent infection with monkeypox. The WHO believes that increasing frequency of worldwide infection may be related to waning immunity against smallpox, since that disease was eradicated in 1980 and the vaccine is no longer popularly used. TransmissionAnimal to human – contact with sick or dead animals, ingesting poorly cooked meat of infected animals.Human to human -” Human-to-human transmission is thought to occur primarily through large respiratory droplets. Respiratory droplets generally cannot travel more than a few feet, so prolonged face-to-face contact is required. Other human-to-human methods of transmission include direct contact with body fluids or lesion material, and indirect contact with lesion material, such as through contaminated clothing or linens.” (CDC)SymptomsInitial 1-3 days – fever, lymphadenopathy, back pain, headache, myalgias, fatigue2-4 weeks of rash progression: macules -> papules -> vesicles -> pustules -> scabsThe pox rash starts on the face and spreads to the rest of the body.TestingDetection is by PCR testing, ideally of body fluid contained in the pox blisters.Test kits are available through local U.S. Health Departments and the CDC. All suspected cases should be reported to local authorities.TreatmentTreatment includes vaccinating anyone who has been exposed with the smallpox vaccine (ring vaccination). The general population is no longer routinely vaccinated due to side-effects of the smallpox vaccine.No current recommendation exists for antiviral therapy or smallpox immunoglobulin therapy.  See CDC recommendations PreventionThe JYNNEOS vaccine was FDA approved in 2019 for adults > 18 against both smallpox and monkeypox. It is a 2 dose non-replicating attenuated virus that does not produce a lesion, and therefore can not cause transmission to others. The CDC Advisory Committee on Immunization Practices is currently evaluating vaccine data with a formal recommendation pending. Media reports note the U.S. government has ordered millions of doses. The original smallpox vaccine (DRYVAX) is no longer in production. However, a second generation clone, ACAM2000, is produced by Synofi and approved by the FDA. The WHO notes that smallpox vaccine is 85% effective in preventing monkeypox.Vaccination is recommended for lab workers and anyone exposed to monkeypox. The CDC recommends vaccination within 4 days of exposure to prevent disease, with ACAM2000. However, vaccination between days 4-14 is also recommended to reduce disease severity. Vaccination does carry risks. The CDC estimates “Based on past experience, it is estimated that between 1 and 2 people out of every 1 million people vaccinated will die as a result of life-threatening complications from the vaccine” (ACAM2000) but notes that disease fatally is 1-10% outweighing the risk of vaccination. Further ReadingCurrent WHO Outbreak TrackerCDC Monkeypox ReferenceJohns Hopkins Monkeypox Reference

A brief summary of what you need to know if you work in the emergency department or urgent care. Epidemiology Caused by double stranded DNA virus, genus orthopoxvirus, closely related to smallpox and cowpox.Discovered in 1958 in monkeys with first human case recorded in 1970 in the Democratic Republic of Congo. (CDC) It is a zoonotic disease , meaning it is transmitted from animal to humans, with primary reservoir in squirrels, Gambian poached rats, dormice, different species of monkeys and others.  First reported in the U.S. in 2003. Cases were related to pet prairie dogs that had been housed with monkeypox virus infected African rodents, imported from Ghana (WHO)There are 2 clades (having evolved from same ancestral line) of the disease. The current outbreak is from the West African lineage. (WHO)West African - milder disease, 1-3% fatalityCongo Basin - severe disease, 10% fatality Due to the similarity in the viruses, immunization against smallpox has been found to prevent infection with monkeypox. The WHO believes that increasing frequency of worldwide infection may be related to waning immunity against smallpox, since that disease was eradicated in 1980 and the vaccine is no longer popularly used.  Transmission Animal to human - contact with sick or dead animals, ingesting poorly cooked meat of infected animals.Human to human -" Human-to-human transmission is thought to occur primarily through large respiratory droplets. Respiratory droplets generally cannot travel more than a few feet, so prolonged face-to-face contact is required. Other human-to-human methods of transmission include direct contact with body fluids or lesion material, and indirect contact with lesion material, such as through contaminated clothing or linens." (CDC) Symptoms Initial 1-3 days - fever, lymphadenopathy, back pain, headache, myalgias, fatigue2-4 weeks of rash progression: macules -> papules -> vesicles -> pustules -> scabsThe pox rash starts on the face and spreads to the rest of the body. Source: CDC Testing Detection is by PCR testing, ideally of body fluid contained in the pox blisters.Test kits are available through local U.S. Health Departments and the CDC. All suspected cases should be reported to local authorities. Treatment Treatment includes vaccinating anyone who has been exposed with the smallpox vaccine (ring vaccination). The general population is no longer routinely vaccinated due to side-effects of the smallpox vaccine. No current recommendation exists for antiviral therapy or smallpox immunoglobulin therapy.  See CDC recommendations  Prevention The JYNNEOS vaccine was FDA approved in 2019 for adults > 18 against both smallpox and monkeypox. It is a 2 dose non-replicating attenuated virus that does not produce a lesion, and therefore can not cause transmission to others. The CDC Advisory Committee on Immunization Practices is currently evaluating vaccine data with a formal recommendation pending. Media reports note the U.S. government has ordered millions of doses. The original smallpox vaccine (DRYVAX) is no longer in production. However, a second generation clone, ACAM2000, is produced by Synofi and approved by the FDA. The WHO notes that smallpox vaccine is 85% effective in preventing monkeypox.Vaccination is recommended for lab workers and anyone exposed to monkeypox. The CDC recommends vaccination within 4 days of exposure to prevent disease, with ACAM2000. However, vaccination between days 4-14 is also recommended to reduce disease severity. Vaccination does carry risks. The CDC estimates "Based on past experience, it is estimated that between 1 and 2 people out of every 1 million people vaccinated will die as a result of life-threatening complications from the vaccine"  (ACAM2000) but notes that disease fatally is 1-10% outweighing the risk of vaccination.  Further Reading Current WHO Outbreak TrackerCDC Monkeypox ReferenceJohns Hopkins Monkeypox Reference

A brief summary of what you need to know if you work in the emergency department. Epidemiology Caused by double stranded DNA virus, genus orthopoxvirus, closely related to smallpox and cowpox.Discovered in 1958 in monkeys with first human case recorded in 1970 in the Democratic Republic of Congo. (CDC) It is a zoonotic disease , meaning it is transmitted from animal to humans, with primary reservoir in squirrels, Gambian poached rats, dormice, different species of monkeys and others.  First reported in the U.S. in 2003. Cases were related to pet prairie dogs that had been housed with monkeypox virus infected African rodents, imported from Ghana (WHO)There are 2 clades (having evolved from same ancestral line) of the disease. The current outbreak is from the West African lineage. (WHO)West African - milder disease, 1-3% fatalityCongo Basin - severe disease, 10% fatality Due to the similarity in the viruses, immunization against smallpox has been found to prevent infection with monkeypox. The WHO believes that increasing frequency of worldwide infection may be related to waning immunity against smallpox, since that disease was eradicated in 1980 and the vaccine is no longer popularly used.  Transmission Animal to human - contact with sick or dead animals, ingesting poorly cooked meat of infected animals.Human to human -" Human-to-human transmission is thought to occur primarily through large respiratory droplets. Respiratory droplets generally cannot travel more than a few feet, so prolonged face-to-face contact is required. Other human-to-human methods of transmission include direct contact with body fluids or lesion material, and indirect contact with lesion material, such as through contaminated clothing or linens." (CDC) Symptoms Initial 1-3 days - fever, lymphadenopathy, back pain, headache, myalgias, fatigue2-4 weeks of rash progression: macules -> papules -> vesicles -> pustules -> scabsThe pox rash starts on the face and spreads to the rest of the body. Source: CDC Testing Detection is by PCR testing, ideally of body fluid contained in the pox blisters.Test kits are available through local U.S. Health Departments and the CDC. All suspected cases should be reported to local authorities. Treatment Treatment includes vaccinating anyone who has been exposed with the smallpox vaccine (ring vaccination). The general population is no longer routinely vaccinated due to side-effects of the smallpox vaccine. No current recommendation exists for antiviral therapy or smallpox immunoglobulin therapy.  See CDC recommendations  Prevention The JYNNEOS vaccine was FDA approved in 2019 for adults > 18 against both smallpox and monkeypox. It is a 2 dose non-replicating attenuated virus that does not produce a lesion, and therefore can not cause transmission to others. The CDC Advisory Committee on Immunization Practices is currently evaluating vaccine data with a formal recommendation pending. Media reports note the U.S. government has ordered millions of doses. The original smallpox vaccine (DRYVAX) is no longer in production. However, a second generation clone, ACAM2000, is produced by Synofi and approved by the FDA. The WHO notes that smallpox vaccine is 85% effective in preventing monkeypox.Vaccination is recommended for lab workers and anyone exposed to monkeypox. The CDC recommends vaccination within 4 days of exposure to prevent disease, with ACAM2000. However, vaccination between days 4-14 is also recommended to reduce disease severity. Vaccination does carry risks. The CDC estimates "Based on past experience, it is estimated that between 1 and 2 people out of every 1 million people vaccinated will die as a result of life-threatening complications from the vaccine"  (ACAM2000) but notes that disease fatally is 1-10% outweighing the risk of vaccination.  Further Reading Current WHO Outbreak TrackerCDC Monkeypox ReferenceJohns Hopkins Monkeypox Reference

Welcome to E41, where we talk about the old and sometimes creative, sometimes offensive terms for illnesses.  Listener beware this one gets kinda gross! Please leave us a 5 star review on Apple, Spotify and anywhere that takes reviews.  Also share us with a friend or two.We're going to Puerto Rico!  If you've been please share your recommendations either on social media or email the show at loreofthesouth@gmail.comcitations Centers for Disease Control and Prevention. (2021, December 16). Dengue vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. Centers for Disease Control and Prevention. Retrieved April 16, 2022, from https://www.cdc.gov/mmwr/volumes/70/rr/rr7006a1.htm Centers for Disease Control and Prevention. (2021, September 23). About dengue: What you need to know. Centers for Disease Control and Prevention. Retrieved April 16, 2022, from https://www.cdc.gov/dengue/about/index.html Dengue vaccine. Dengue Vaccine - an overview | ScienceDirect Topics. (n.d.). Retrieved April 16, 2022, from https://www.sciencedirect.com/topics/immunology-and-microbiology/dengue-vaccine Editorial TeamAugust 18, 2021. (n.d.). Malaria risk & sickle cell. Sickle. Retrieved April 17, 2022, from https://sickle-cell.com/clinical/malaria Hogg, P. (2021, June 21). The top 10 medical advances in history. Proclinical.com. Retrieved April 14, 2022, from https://www.proclinical.com/blogs/2021-6/the-top-10-medical-advances-in-history Old diseases found on death certificates. (n.d.). Retrieved April 14, 2022, from http://www.usgennet.org/usa/ar/county/greene/olddiseases1.htm Torrey, T. (2021, March 11). From dropsy to the grip: Modern terms for outdated diagnoses. Verywell Health. Retrieved April 10, 2022, from https://www.verywellhealth.com/outdated-disease-names-2615295 Wikimedia Foundation. (2021, December 2). List of deprecated terms for diseases. Wikipedia. Retrieved April 10, 2022, from https://en.wikipedia.org/wiki/List_of_deprecated_terms_for_diseases Wikimedia Foundation. (2022, April 12). Malaria. Wikipedia. Retrieved April 17, 2022, from https://en.wikipedia.org/wiki/Malaria World's first dengue vaccine originated from SLU Research. SLU. (n.d.). Retrieved April 16, 2022, from https://www.slu.edu/news/2015/december/dengue-vaccine.php 

Episode 86: Abdominal Pain Case. Spikevax® is the brand name of the Moderna COVID-19, and it received full FDA approval in January 2022. Hepatitis B vaccine is now universally recommended to all adults between 19-59 years of age, or older than 60 with risk factors. Deidra Sieck presents a case of abdominal pain in pregnancy and differential diagnosis are discussed.  Introduction: Spikevax ® and Hepatitis B universal vaccination.  Written by Hector Arreaza, MD. Participation by Cecilia Covenas, MD.Spikevax®. This is the brand name given to the mRNA COVID-19 vaccine manufactured by Moderna. It was given full FDA approval for the prevention of COVID-19 in adults 18 years and older. This is the second vaccine approved by the FDA for the prevention of COVID-19 (the first vaccine was Comirnaty®, formerly known as Pfizer Vaccine.) The primary series of Spikevax for immunocompetent adults is comprised of 2 doses, 4 weeks apart. Immunocompromised patients receive a 3rd dose as part of the primary series, one month after the second dose. A booster shot of Spikevax is given at least 5 months after completing the primary series. Spikevax was also authorized for use as a “mix and match” single booster dose following completion of primary vaccination with a different COVID-19 vaccine. It means that recipients of the Pfizer and J&J vaccines who are 18 years and older may receive a single booster dose of Spikevax. The full FDA approval was granted to Spikevax on January 31, 2022.Did you know that Hepatitis B has killed 40 times more unvaccinated healthcare workers than HIV?  Yes, that's right. Hepatitis B is 50 to 100 times more infectious than HIV. It is transmitted by percutaneous or mucosal exposure to infected blood or other bodily fluids. As a reminder, immunizations against many diseases have been required for health care workers for decades, and hepatitis B is one of those required vaccines. That's not new, what's new is the new recommendation about universal Hep B vaccination. In November 2021, the ACIP (Advisory Committee on Immunization Practices from CDC) recommended universal adult Hepatitis B vaccination. After reviewing clinical evidence, the ACIP has unanimously voted to recommend the Hep B vaccine for all adults ages 19-59. Patients who should receive hep B vaccines are: all adults between 19 and 59 years of age, and adults older than 60 with risk factors for hepatitis B infection. However, adults older than 60 without risk factors may also receive hep B vaccines. Vaccinating against Hep B is done to decrease new infections, prevent transmission, and reduce health disparities. HHS has called for the elimination of viral hepatitis as a public health threat by 2030. There are some reasons to recommend universal Hep B vaccination for adults: many infected patients did not have any risk factors for infection and still got infected; almost 85% of adults in the U.S. fall into a higher-risk group, including patients with diabetes and kidney disease; hepatitis B cases in the U.S. rose by 11% between 2014 and 2018 despite having highly effective vaccines; Hep B is one of the primary causes of liver cancer, one of the deadliest cancers; universal vaccination of newborns started in 1991 in the U.S., so, many adults are not immune to Hep B, but now they can be vaccinated without the many restrictions imposed in the past.Remember, Spikevax is the new name for the Moderna vaccine; and you can start vaccinating all adults between 19 and 59 years of age against hep B, regardless of risk factors.This is Rio Bravo qWeek, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California. Our program is affiliated with UCLA, and it's sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home.___________________________Abdominal Pain Case.  By Deidra Sieck, MS4, Ross University School of Medicine. Hosted by Hector Arreaza, MD.   Abdominal pain in pregnancy is quite common and has a wide differential. I want to begin with a case and then highlight a few of the “do-not-miss” diagnoses when a patient comes with the chief complaint of abdominal pain during her pregnancy. Case presentation: 23-year-old G2P1 at 32 weeks of gestation complains of 12 hours of right lower quadrant abdominal pain, anorexia, and nausea with vomiting. She denies vaginal bleeding or leakage of fluid from the vagina. Denies diarrhea or eating stale foods. No medical history and has been in good health. Denies dysuria and has had no previous surgeries. Her vital signs include a blood pressure of 100/70 mm Hg, heart rate of 105 beats per minute, and temperature of 101.5 F. On abdominal examination, bowel sounds are hypoactive. The abdomen is tender in the right lower quadrant to right flank with significant involuntary guarding. The cervix is closed. The fetal heart tones are in the range of 160 BMP (modified vignette from case files obstetrics and gynecology 5th ed.)What are some of the differentials that come to mind? The 6 differentials that should come to mind that are do not miss diagnoses include:  Placental abruptionAppendicitis Cholecystitis Ectopic Pregnancy Hemorrhagic cyst Ovarian TorsionI want to discuss each of these diagnoses and then devise a plan for the patient in this case. Placental abruptionThis is the most common cause of third trimester bleeding and is an obstetric emergency. It occurs during the second and third trimesters and is described as a midline persistent suprapubic pain. The pain is also accompanied by vaginal bleeding as well as an abnormal fetal heart rate tracing.  Mothers at risk have had a previous abruption, hypertension during the pregnancy, cocaine use, smoking, or preterm premature rupture of the membranes, or trauma as the most common cause of the abruption. This diagnosis is made clinically. The ultrasound is an unreliable modality to see the abruption. If the mother is stable and it is not a complete abruption, the mother usually delivers the baby very quickly vaginally. However, if the abruption is complete, the fetal heart tracing is category III, or the mother is hemodynamically unstable, it is best to deliver by c-section. Appendicitis. Appendicitis can occur any trimester during pregnancy and has been found to occur in 0.1-1.4/1000 pregnancies. The typical nonpregnant patient with appendicitis will come with complaints of right lower quadrant pain that may radiate to the right upper quadrant. This is usually associated with other complaints of nausea, vomiting, anorexia, or fever. [Anorexia: 80% sensitive, The sign of the hamburger] However, this diagnosis may be missed later in pregnancy because of an atypical presentation. As the gravid uterus grows, it can displace the appendix upward and lateral toward the flank. This leads to a presentation that appears to be more consistent with pyelonephritis, leading to a missed diagnosis. Because of the delay in diagnosis pregnant women are 2-3 times more likely to have a ruptured appendix, and the resulting peritonitis increases the likelihood of morbidity and mortality for the patient.  If appendicitis progresses to appendiceal rupture, there is a 30% chance of spontaneous abortion of the fetus. These patients need an ultrasound to make the diagnosis since they cannot have a CT scan in pregnancy despite a CT scan being the preferred modality in nonpregnant patients. The ultrasound should show a non-compressible, blind-ended tubular structure in the right lower quadrant with a maximal diameter greater than 6mm.After the ultrasound confirms the diagnosis, these patients should be taken immediately for an appendectomy. However, the decreased resolution of imaging seen with ultrasound can also lead to delays in these patients receiving the appendectomy.Cholecystitis. Cholecystitis is more common in pregnancy, with occurrence in 1/1600 pregnancies. This can occur anytime in pregnancy after the first trimester. Pregnant women are especially high risk of cholecystitis since they are female and fertile. The other two “f's” that are commonly listed as risk factors for cholecystitis include forty, and obesity. [the F word is banned in this podcast]. Pathophysiology: The increased progesterone and estrogen increase bile lithogenicity. Progesterone also decreases gallbladder contractility. This increase in gallbladder volume and decreased contractility lead to an increase in “biliary sludge” in the gallbladder. The biliary sludge acts as a precursor to gallstones and obstruction of the cystic duct or the common bile duct. The patient with cholecystitis typically comes with complaints of pain in the right upper quadrant which can be associated with nausea, vomiting, anorexia, and fever. This is the same presentation as a patient in pregnancy. The complication of missing this diagnosis includes secondary infection with enteric flora such as: E. coli, Klebsiella, and Enterococcus faecalis.  Fetal loss is seen in 3-20% of pregnancies complicated by cholecystitis. The diagnosis is made with a careful history as well as an ultrasound showing gallstones with dilation and thickening of the gallbladder and gallbladder wall. Treatment should be started with bowel rest, IV hydration, correction of electrolytes, analgesics. They should be given antibiotics if no improvement after 12-24 hours or are experiencing systemic symptoms. If the medical management does not work, these patients should have a cholecystectomy.  The cholecystectomy will most likely be laparoscopic due to the gravid uterus making it difficult to perform an open approach. If in the third trimester and the patient is stable, the surgeon may opt to wait until after delivery to remove the gallbladder.Ectopic pregnancy. This is the leading cause of maternal mortality in the first and second trimesters. It usually presents during the first trimester as pelvic or abdominal pain that is usually unilateral. The patient could also complain of nausea, vomiting, syncope, or vaginal spotting. The diagnosis is made using a serum hCG that meets the threshold and transvaginal ultrasound. The treatment can be surgical or medical. If the pregnancy is early, methotrexate can be used. However, the hCG needs to be trended and followed to zero. A D&C can also be used to treat ectopic pregnancy. Surgery is the first treatment in a patient that is hemodynamically unstable. This diagnosis is not likely in our patient.Ruptured corpus luteum or ruptured hemorrhagic cyst. The corpus luteum cyst is part of a normal endocrine function or a result of prolonged progesterone. In pregnancy, the corpus luteum produces progesterone until 7-10 weeks' gestation until the placenta can produce steroids including hCG and progesterone to maintain the pregnancy. However, intrafollicular bleeding can occur because of the thin-walled capillaries that invade the granulosa cells from the theca interna. If there is excessive hemorrhage, the cyst can enlarge and rupture. The patients presenting with this complaint present with unilateral cramping and lower abdominal pain 1-2 weeks before the rupture. If the corpus luteum becomes hemorrhagic, a hemoperitoneum can develop. These women should undergo an ultrasound, which will show free intraperitoneal fluid. This could also include some fluid around the ovary. The confirmatory method for diagnosis is laparoscopy. Culdocentesis is a procedure that checks for abnormal fluid in the space just behind the vagina. This area is called the cul-de-sac. During a culdocentesis, a long thin needle is inserted through the vaginal wall just below the uterus and a sample is taken of the fluid within the abdominal cavity.Once the bleeding is controlled, there is no further treatment needed. However, if the patient requires a cystectomy due to continued bleeding and the pregnancy is less than 10 weeks, she will need exogenous progesterone because of the loss of the corpus luteum. Ovarian Torsion. Pregnancy is a risk factor for ovarian torsion, especially around 14 weeks and after delivery. Torsion is most likely between 10-17 weeks, and more likely to happen in masses 6-8 cm in diameter. Pregnant and nonpregnant patients have the same presentation, suprapubic or lower quadrant pain, nausea, and vomiting, up to 20% can have a fever. Plan for the patient in the case:1. Ultrasound: Showed a non-compressible, blind-ended tubular structure in the right lower quadrant with a maximal diameter of 7mm.2. Appendectomy: Take the patient to the OR.____________________________Now we conclude our episode number 86 “Abdominal Pain Case.” We started by giving you an update on Spikevax®, formerly known as “the Moderna vaccine”. This is the newest COVID-19 vaccine fully approved by the FDA for patients 18 years and older. Also, Hepatitis B vaccination is now recommended universally to all adults 19-59 regardless of risk factors. Then, Deidra presented a case of a patient who was pregnant and had abdominal pain. Surprisingly, her diagnosis was appendicitis. This is a good reminder that pregnant and nonpregnant patients can get appendicitis. Even without trying, every night you go to bed being a little wiser.Thanks for listening to Rio Bravo qWeek. If you have any feedback about this podcast, contact us by email RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. This podcast was created for educational purposes only. Visit your primary care physician for additional medical advice. This week we thank Hector Arreaza, Cecilia Covenas, and Deidra Sieck. Audio edition: Suraj Amrutia. See you next week! _____________________References:Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine, US Food and Drug Administration, January 31, 2022. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine. ACIP fully recommends Spikevax, as CDC expands wastewater surveillance, University of Minnesota, Center for Infectious Disease Research and Policy (CIDRAP), February 04, 2022. https://www.cidrap.umn.edu/news-perspective/2022/02/acip-fully-recommends-spikevax-cdc-expands-wastewater-surveillance.  ACIP recommends universal hepatitis B vaccination for adults aged 19 to 59 years, Healio.com, https://www.healio.com/news/infectious-disease/20211103/acip-recommends-universal-hepatitis-b-vaccination-for-adults-aged-19-to-59-years. Landmark vote by CDC's Advisory Committee on Immunization Practices (ACIP) to recommend universal hepatitis B vaccination, Hepatitis B Foundation, November 4, 2021. https://www.hepb.org/news-and-events/news-2/the-cdcs-advisory-committee-on-immunization-practices-acip-voted-to-recommend-universal-hepatitis-b-vaccination/ Ananth, Cande Vanessa V, and Wendy L Kinzler. “Placental Abruption: Pathophysiology, Clinical Features, Diagnosis, and Consequences.” Edited by Charles J Lockwood, and Vanessa A Barss,  22 Feb. 2021, https://www.uptodate.com/contents/placental-abruption-pathophysiology-clinical-features-diagnosis-and-consequences.  Brooks, David C. Edited by Stanley W Ashley et al., Gallstone Disease in Pregnancy, 26 July 2021, https://www.uptodate.com/contents/gallstone-diseases-in-pregnancy.   H., De Cherney Alan, et al. “Chapter 25: Surgical Disorders In Pregnancy.” Current Diagnosis and Treatment: Obstetrics and Gynecology, McGraw Hill Medical Publishing Division, 2019.  “Obstetrics and Gynecology.” Case Files: Obstetrics and Gynecology 5th Edition, by Eugene C. Toy et al., McGraw-Hill Medical, 2016, pp. 135–144.  Rebarber, Andrei, et al. “Acute Appendicitis in Pregnancy.” Edited by Martin Weiser et al., Up To Date , 17 Sept. 2021, https://www.uptodate.com/contents/acute-appendicitis-in-pregnancy.  Runowicz, Carolyn D, and Molly Brewer. “Adnexal Mass in Pregnancy.” Edited by Barbara Goff and Alana Chakrabarti, UpToDate, 10 Feb. 2022, https://www.uptodate.com/contents/adnexal-mass-in-pregnancy.  Tulandi, Togas. “Ectopic Pregnancy: Clinical Manifestations and Diagnosis.” Edited by Deborah Levine et al., UpToDate, 18 Jan. 2022, https://www.uptodate.com/contents/ectopic-pregnancy-clinical-manifestations-and-diagnosis.

Dr. Paul Offit is a pediatrician specializing in infectious diseases and an expert on vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine that has been credited with saving hundreds of lives every day. Dr. Offit is the Maurice R. Hilleman professor of vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania and director of The Vaccine Education Center at Children's Hospital of Philadelphia (CHOP). Offit is currently a member of National Institutes of Health (NIH) working group on vaccines, a subgroup of the "Accelerating COVID-19 Therapeutic Interventions and Vaccines" (ACTIV) comprised of experts to combat COVID-19. He is also a member of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC). Previously, he was a member of the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices. Offit is a board member of Vaccinate Your Family, The Franklin Institute, and Autism Science Foundation.  "You Bet Your Life" is his 12th book.Find out more about Dr. Offit and this episode at: https://www.nicupodcast.com________________________________________________________________________________________As always, feel free to send us questions, comments or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through instagram or twitter, @nicupodcast. Or contact Ben and Daphna directly via their twitter profiles: @drnicu and @doctordaphnamd. enjoy!This podcast is proudly sponsored by Chiesi.

After the U.S. administered nearly 7 million doses of the Johnson & Johnson COVID-19 vaccine, the CDC and FDA this morning issued a recommendation to pause using that particular vaccine after six women developed blood clots following their vaccinations.  Dan discusses how this recommendation was likely made, why and how to understand it with Julie Morita, executive vice president of the Robert Wood Johnson Foundation, who has served on the CDC's Advisory Committee on Immunization Practices, as commissioner for the Chicago Department of Public Health, and on the Biden Covid-19 advisory board. Learn more about your ad choices. Visit megaphone.fm/adchoices

An influential Covid-19 model from the University of Washington predicts there will be 562,000 deaths by April 1st. If 95% of people wore masks, 55,000 lives could be saved. Dr. Chris Murray is the director of the group at the University of Washington that’s been working on these models throughout the pandemic. He joins AC360 to discuss when he thinks the vaccines will make a major dent on the daily death rate. Plus, the FDA has issued emergency use authorization for Moderna’s Covid-19 vaccine. Dr. William Schaffner is a professor at the Division of Infectious Diseases at Vanderbilt University Medical Center and is also a member of the CDC Advisory Committee on Immunization Practices. He tells AC360 that getting the Moderna vaccine to rural hospitals and health departments will be much easier because it doesn’t have the intense, cold storage requirements that the Pfizer vaccine has. Airdate: December 18, 2020 Guests: Dr. Chris Murray Dr. William SchaffnerTo learn more about how CNN protects listener privacy, visit cnn.com/privacy